Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.75 GBX | 0.00% | 0.00% | -77.50% |
Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
Apr. 25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.04M 19.14M |
---|---|---|---|---|---|
Net income 2024 * | -5M -6.36M | Net income 2025 * | -8M -10.18M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.55M 1.97M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.58
x | P/E ratio 2025 * |
-1.85
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.4% |
Latest transcript on Destiny Pharma plc
1 month | -7.35% | ||
3 months | -50.00% | ||
6 months | -79.14% | ||
Current year | -77.50% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 23-08-31 | |
William Love
FOU | Founder | 62 | 96-03-03 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 11-08-31 |
William Love
FOU | Founder | 62 | 96-03-03 |
Nigel Brooksby
BRD | Director/Board Member | - | 22-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 15.75 | 0.00% | 322,150 |
24-06-06 | 15.75 | -4.55% | 214,563 |
24-06-05 | 16.5 | +4.76% | 204,700 |
24-06-04 | 15.75 | 0.00% | 877,633 |
24-06-03 | 15.75 | 0.00% | 12,081 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.50% | 19.14M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- DEST Stock